Log in

Pharmacists, patients are stuck in the middle of a profit-before-all-else pharmacy racket By SCOTT KNOER FEBRUARY 24, 2020 ADOBE

  • 26 Feb 2020 8:40 AM
    Message # 8771296
    Anonymous member (Administrator)

    The news that chaos reigns inside chain pharmacies, putting patients at risk, may have come as a shock to readers but it’s no surprise to any pharmacist, pharmacy technician, or pharmacy student, all of whom know that the system is broken.

    Ellen Gabler’s exposé in the New York Times showed how big chain pharmacies sacrifice patient safety by placing unreasonable volume and speed demands on pharmacists. It highlighted how pharmacy staff are under-resourced, over-worked, and discouraged from speaking out about conditions they feel are putting patients in harm’s way.

    Intense financial pressure combined with the volume-based reimbursement that drive the constant push for more pills are compromising patient care and pharmacist well-being. The payment model for medications is damaged beyond repair and must rebuilt from the ground up to ensure that all prescriptions are filled correctly and safely.

    As the chief pharmacy officer for the Cleveland Clinic, I’ve spent the last nine years working to care for patients in our hospitals, clinics, family health centers, and 20 community pharmacies.

    Our teams are held to exceptionally high standards, with a multitude of payer contracts that grade our overall health system on its performance and quality and put the organization’s revenue at risk when we drop the ball or achieve poor outcomes like high readmission rates. While these value-based payment models are works in progress that need to be perfected over time, they represent an important philosophical concept that patients are better served when the system pays for a desired outcome instead of the completion of a service or transaction.

    Large for-profit pharmacies operate with a different set of expectations and standards.

    The vast majority of their pharmacy revenue streams are predicated on filling prescriptions. The payment system asks pharmacies for little more than “Did you fill it?”

    It’s no wonder, then, that in order to make more money you have to fill more prescriptions — and bigger profits can be generated by filling them faster and faster. As the need for speed increases, quality, error rates, customer service, and outcomes decline. But no one is tracking these metrics.

    This drives up health care costs as patients take the wrong medications or incorrect doses of the right ones, or take unnecessary and duplicate medications, or those with harmful drug-drug interactions — all things a careful pharmacist can detect beforehand.

    Declining quality or safety don’t bother many members of the drug supply chain. They are tickled pink with this. More pills equal more cash for them.

    The prescription drug supply chain and payment system are a mess. Pharmacists, who graduate as Doctors of Pharmacy after intense didactic and experiential training, are stuck in the middle of this profit-before-all-else racket — along with the patients they serve.

    Pharmaceutical manufacturers, wholesalers, pharmacies, pharmacy benefit managers, insurance companies, and others have created a system that is distorted, opaque, and working against the interests of patients. The enormity of the problem leaves many of my pharmacist colleagues feeling helpless.

    While there is a litany of complicated issues that must be addressed across the prescription drug supply chain, the most immediate one is delivering safe, high-quality medicines to patients. This is what pharmacists are trained to do but, as the Times showed, the industry in which they practice is taking shortcuts that compromise their ability to do what they went to school for. And it puts their patients in harm’s way.

    Pharmacists need to take back control of their profession from those who seek to exploit their talents to merely pump out more pills and drive short-term quarterly earnings.

    Pharmacists have the skills to improve transitions of care from hospitals to home, maximize drug therapy regimens, add value to the health care team, and actively manage diseases like diabetes and high blood pressure by monitoring patients and changing and adjusting their medications. That’s exactly what pharmacists do in health systems like the Cleveland Clinic, Geisinger Clinic, the Veterans Health Administration, and Kaiser Permanente, to name a few. Community pharmacists want to do this kind of work, but often aren’t allowed to do much more than fill prescriptions as fast as they can.

    Solving the problems in pharmacy should start by elevating the role of pharmacists from one resembling fast food workers to the clinical, patient-focused positions they trained for and dedicate their professional lives to. We must end the era of high volume and speed. And we must build incentives — and disincentives — into the pharmacy care delivery model that reward those who uphold high practice standards and punish those who cut corners around safety and quality.

    Fixing this mess will take serious policy changes. Pharmacists need to be the driving force to make them happen.

    Scott Knoer, Pharm.D., is the chief pharmacy officer of the Cleveland Clinic.

    About the Author  Scott Knoer   knoers@ccf.org   @ScottKnoer ‏

    go to original article

    Last modified: 26 Feb 2020 11:59 AM | Anonymous member (Administrator)
  • 26 Feb 2020 8:46 AM
    Reply # 8771314 on 8771296
    Anonymous member (Administrator)

    ·    FEBRUARY 25, 2020 AT 2:09 PM

    Changes, such as what the Nursing Profession undertook, happen at the legislative level. And it requires Pharmacists knowledgeable in the legislative process of advocacy, and that has to begin in Pharmacy Schools. Some schools, such as Temple School of Pharmacy actually had an elective that did just that.
    In order to be effective that type of course should be in all Pharmacy Schools and be a required “elective”.

    ·   FEBRUARY 25, 2020 AT 1:57 PM

    Scott Knoer is well-suited for his next role as CEO and EVP of the American Pharmacists Association. Together we have learned we will influence policies and support changes by incentivising the outcomes we seek.

    ·    FEBRUARY 25, 2020 AT 10:31 AM

    I think this piece is short on solutions and facts. Cleveland Clinic pumps out more Rx’s than most. If more pills do not equate to more care, why does Scott write one thing, but demand another in his own shop? Who is paying for all those shiny new buildings and robots that Cleveland has anyway? The margins on infused drugs is obscene and I don’t believe anyone is pointing that out to Scott or pressuring him to lower those rates. It’s good for him that health plans, employers, and patients are not rioting in front of their cancer centers or his specialty pharmacy. He would not have real solutions or facts on his side. Maybe APhA can show us the way.

    Last modified: 26 Feb 2020 11:57 AM | Anonymous member (Administrator)


New Hampshire Pharmacists Association 

373 South Willow Street  D1-1, Suite 165

Manchester, NH 03103

Email: info@nhpharmacists.net

NHPA Mission Statement

The mission of the New Hampshire Pharmacists Association is to promote, enhance, and advance pharmacy practice, in the State of New Hampshire by advocating for the professional interests of pharmacists, pharmacy technicians, student pharmacists, and ancillary pharmacy personnel as well as to advocate for the health and welfare of the general public.

Signup For Our Mailing List

You will only receive notification about our CE Programs, Dinner Social Events, and legislative alerts. Our list is never shared or sold for any reason.


Event Cancellation Policy

Your NHPA website has been updated and is now smartphone friendly.

Please take the time to view the website from your laptop as well as from your smartphone. 

We look forward to your comments and suggestions.


Powered by Wild Apricot Membership Software